Prosight Management
Prosight Management reported 32 stocks worth $515M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are LKFT (11.5%), STTK (10.1%) and JANX (9.9%). Compared with Q2 2026, the fund opened new positions in PRVA, DNLI and PRAX, added to STTK, ABVX and IRTC, trimmed LKFT, JANX and NKTR and sold out of VEEV, ICUI and ISRG.
Latest filing: what Prosight Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() LKFT Galapagos NV | $59.3M | 11.5% | 2M | −45K (−2%) | 8 of 8 | |
| 2 | ![]() STTK Shattuck Labs Inc | $52.2M | 10.1% | 7.6M | +1.7M (+28%) | 8 of 8 | |
| 3 | ![]() JANX Janux Therapeutics Inc | $50.9M | 9.9% | 2.9M | −861K (−23%) | 8 of 8 | |
| 4 | ![]() NKTR Nektar Therapeutics | $47.5M | 9.2% | 785K | −25K (−3%) | 4 of 8 | |
| 5 | ![]() ABVX Abivax SA | $37.3M | 7.2% | 377K | +269K (+251%) | 4 of 8 | |
| 6 | ![]() INSM Insmed Inc | $27.2M | 5.3% | 238K | −138K (−37%) | 2 of 8 | |
| 7 | ![]() BSX Boston Scientific Corp | $24M | 4.7% | 550K | −720K (−57%) | 5 of 8 | |
| 8 | ![]() IRTC Irhythm Technologies Inc | $22.8M | 4.4% | 201K | +35K (+21%) | 3 of 8 | |
| 9 | ![]() ALKS Alkermes PLC | $22.3M | 4.3% | 550K | +156K (+39%) | 3 of 8 | |
| 10 | ![]() PRVA Privia Health Group Inc | $20.7M | 4.0% | 1M | New position | 1 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
![]() VEEV Veeva Sys Inc Class Class A | $18.8M | 106K |
CRINETICS PHARMACEUTICALS IN | $14M | 375K |
![]() ICUI Icu Med Inc | $7.5M | 51K |
![]() ISRG Intuitive Surgical Inc | $6.8M | 17K |
![]() PRCT Procept Biorobotics Corp | $6.1M | 268K |
🔒 Free account: see all 13.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 13, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Prosight Management 13F FAQ
What does Prosight Management own?
Prosight Management reported 32 stocks worth $515M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are LKFT (11.5%), STTK (10.1%) and JANX (9.9%). The table above lists every position in the filing (the top 10 without an account).
What did Prosight Management buy and sell in Q3 2026?
Compared with Q2 2026: 9 new positions, 11 added to, 12 trimmed and 13 sold out. New positions include PRVA, DNLI and PRAX. It sold all of VEEV, ICUI and ISRG.
When will Prosight Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Prosight Management's portfolio worth?
The Q3 2026 filing reports $515M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.




















